14、orin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerJ.J Clin Oncol,2000,18(16):2938一2947.4. Andre T, Boni C, Mounedji2Boudiaf L, et al. Oxalip latin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med...
8.Andre T, Boni C, Mounedji-Boudiaf L,et al.Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.N Engl J Med 2004; 350:2343-2351. 9.Andre T, Boni C, Navarro M, et al.Improved overall survival with oxaliplatin, fluorourac...
8.Andre T, Boni C, Mounedji-Boudiaf L,et al.Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.N Engl J Med 2004; 350:2343-2351. 9.Andre T, Boni C, Navarro M, et al.Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment...
with or without oxaliplatin as first-line treatment in advanced colorectal cancer[J].J Clin Oncol,2000,18(16):2938一2947. 4. Andre T, Boni C, Mounedji2Boudiaf L, et al. Oxalip latin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med, 2004, 350: 2343...
BARCELONA (IMNG) - Adding cetuximab to standard adjuvant chemotherapy for resected stage III colon cancer does not benefit patients, according to interim results from a large, phase III, European trial.同济大学附属东方医院胃肠肛肠外科韩俊毅
A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer. J Clin Oncol 2005;23(15):3311-3.Grothey A, Sargent D: FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon ...
2008年度研究生《循证医学WORKSHOP》论文Folfox方案与Folfiri方案治疗晚期大肠癌疗效比较一背景大肠癌是发病率逐年增加的恶性肿瘤,全球发病率居第3位,死亡率居第4位。⑴北美欧洲及澳洲等地区的年发病率高达(30—50)/10万,亚洲地区的发病率较低,每年约8—10/10万,大肠癌的发病部位的发病率依次为直肠、乙状结肠、...
Time to initiation of postoperative chemotherapy: an outcome measure for patients undergoing laparoscopic resection for rectal cancer [J]. Dis Colon Rectum, 2013, 56(8): 945-951. [17] THOMPSON C, WILLIAMS J G. Who should be treating rectal cancer in 2013? [J]. Br J Hosp Med (Lond),...
Surgical Adjuvant Therapy for Colorectal Cancer: Current Approaches and Future Directions Colon cancer is the fourth most common cancer worldwide. The role of systemic adjuvant chemotherapy in colorectal cancer patients with lymph node involveme... Dulabh K. Monga MD,Michael J. O'Connell MD - 《...
Microsatellite Instability and Sensitivitiy to FOLFOX Treatment in Metastatic Colorectal Cancer Microsatelite instability (MSI) is the consequence of the inactivation of a mismatch repair gene and is observed in approximately 15% of colon cancer cases... GD Guetz,P Mariani,J Cucherousset,... - 《...